Cardiac

A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack. Read More

Vanderbilt is the first hospital in Tennessee to use a new subcutaneous implantable defibrillator (S-ICD) to treat patients at risk for sudden cardiac arrest. Read More

Blocking a serotonin receptor may provide a novel therapy for heart valve disease. Read More

Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve. Read More

Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and… Read More

Researchers have identified a gene that increases the risk for developing sick sinus syndrome – the most common cause for implanting a cardiac pacemaker. Read More